Alexandria Real Estate Equities, BioMed, Baxter International, Mack-Cali Realty , Acorda Therapeutics | GenomeWeb
Alexandria, BioMed Report Strong Q1 Earnings
Two publicly traded laboratory owner-manager-developers reported strong first-quarter results earlier this month.
Alexandria Real Estate Equities saw its funds from operations rise 33 percent to $37.5 million during the first three months of 2007, compared with about $28.2 million for the same period last year, on revenues of $97.6 million, up 43 percent from the $68.3 million reported in the year-ago quarter.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.